Health News

To Help Your Kidneys, Check Your Blood Sugar
Even if you don't have full-blown diabetes, your blood sugar could still affect your kidney health.
FDA: Don't Take Diamond 3500
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Diamond 3500, a product promoted and sold for sexual enhancement on various websites and in some retail stores.
FDA Warns Against Sex Enhancement Pill
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Eros Power Zone 1900, a product promoted and sold for sexual enhancement on various websites and in some retail stores.
ED Supplement May Pose Health Risk
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Triple MiracleZen Gold 1750 mg, a product promoted and sold for sexual enhancement on various websites and in some retail stores.
Male Enhancement Product May Pose Health Risk
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Xtra Zone 2400, a product promoted and sold for sexual enhancement on various websites and in some retail stores.
A Potential New Use for Metformin
One common diabetes drug may soon have a new indication.
In Diabetes Emergencies, This Nasal Spray Might Work
When a diabetes patient has severely low blood sugar, you've got to act fast. And an injection might not be the only viable option.
Basaglar Gets FDA Green Light
The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Common Rx Combo Tied to Serious Health Risk
The popular blood thinner warfarin is known for its potentially serious interactions with many drugs. And here may be another.
Type 2 Diabetes Rx May Pose Serious Health Risks
An FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections.